Content on this page is for informational purposes, and is not meant to substitute or replace qualified advice from your healthcare provider. Always consult with a licensed physician to see what treatment options are right for you.
gammaCore is a new treatment option available by prescription for patients suffering from pain associated with episodic cluster headache. gammaCore is not a drug, so there is no need to inject, inhale, or ingest medication. It is a portable, hand-held device that uses nVNS, which can be used safely at home.1
Using gammaCore to stimulate the vagus nerve can help block pain signals caused by cluster attacks. gammaCore was proven safe and effective in 2 clinical trials and can be used to treat multiple attacks per day.1,2
In 2 clinical trials with over 250 patients suffering from cluster headache, gammaCore provided fast relief within 15 minutes of an attack and was well tolerated. gammaCore was not found to be effective among chronic cluster headache patients.1,2
If your healthcare provider prescribes gammaCore to treat pain associated with episodic cluster headache, you have the opportunity to enroll in GPR. The information you share will help electroCore advance its understanding of cluster headache. If you qualify, you may be eligible to receive 2 months of gammaCore at no cost to you and up to 1-year co-pay assistance. For more information about GPR, how to enroll, or to find a center near you, please call 1-888-903-CORE (2673) Monday – Friday 8 AM – 6 PM ET.
gammaCARE™ is a patient support program that offers access to online resources, one-on-one training, and co-pay assistance. gammaCARE is available to all gammaCore patients.
Note: This list is not all inclusive. Please refer to the gammaCore Instructions for Use for all of the important warnings and precautions before using or prescribing this product.
References: 1. gammaCore Instructions for Use. Basking Ridge, NJ: electroCore, LLC.; 2017. 2. Silberstein SD, Mechtler LL, Kudrow DB, et al; Act1 Study Group. Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache. 2016;56(8):1317-1332.